Kimberly (Kim) Belsky is the Executive Director of Regulatory Policy & Intelligence at Mallinckrodt Pharmaceuticals (MNK) assessing key changes in the global regulatory environment and providing strategic insights to the company regarding impact on the portfolio and activities. With over 29 years of global experience in the medical product industry, including 19 years in regulatory affairs, Kim's diverse experience including scale up and tech transfer, quality/compliance, advertising & promotion, labeling, and regulatory policy intelligence. Her background includes Rx drug/biologics, OTCs/Nutritionals/Cosmetics, and medical devices.